1. Home
  2. WAT vs CRBG Comparison

WAT vs CRBG Comparison

Compare WAT & CRBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • CRBG
  • Stock Information
  • Founded
  • WAT 1958
  • CRBG 1957
  • Country
  • WAT United States
  • CRBG United States
  • Employees
  • WAT N/A
  • CRBG N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • CRBG Life Insurance
  • Sector
  • WAT Industrials
  • CRBG Finance
  • Exchange
  • WAT Nasdaq
  • CRBG Nasdaq
  • Market Cap
  • WAT 17.4B
  • CRBG 15.6B
  • IPO Year
  • WAT 1995
  • CRBG 2022
  • Fundamental
  • Price
  • WAT $382.04
  • CRBG $29.29
  • Analyst Decision
  • WAT Buy
  • CRBG Buy
  • Analyst Count
  • WAT 13
  • CRBG 13
  • Target Price
  • WAT $379.00
  • CRBG $39.08
  • AVG Volume (30 Days)
  • WAT 622.0K
  • CRBG 5.1M
  • Earning Date
  • WAT 11-04-2025
  • CRBG 11-03-2025
  • Dividend Yield
  • WAT N/A
  • CRBG 3.28%
  • EPS Growth
  • WAT 3.82
  • CRBG N/A
  • EPS
  • WAT 10.88
  • CRBG 1.78
  • Revenue
  • WAT $3,105,638,000.00
  • CRBG $18,335,000,000.00
  • Revenue This Year
  • WAT $7.12
  • CRBG $0.38
  • Revenue Next Year
  • WAT $6.22
  • CRBG $5.43
  • P/E Ratio
  • WAT $34.87
  • CRBG $16.43
  • Revenue Growth
  • WAT 6.90
  • CRBG 15.16
  • 52 Week Low
  • WAT $275.05
  • CRBG $23.69
  • 52 Week High
  • WAT $423.56
  • CRBG $36.57
  • Technical
  • Relative Strength Index (RSI)
  • WAT 71.09
  • CRBG 34.19
  • Support Level
  • WAT $340.09
  • CRBG $29.36
  • Resistance Level
  • WAT $391.79
  • CRBG $30.51
  • Average True Range (ATR)
  • WAT 10.70
  • CRBG 0.94
  • MACD
  • WAT 1.82
  • CRBG -0.15
  • Stochastic Oscillator
  • WAT 80.65
  • CRBG 1.94

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About CRBG Corebridge Financial Inc.

Corebridge Financial Inc provides retirement solutions and insurance products in the United States. It offers a broad set of products and services through five segments Individual Retirement, Group Retirement, Life Insurance, Institutional Markets businesses, Corporate and Other. The majority of its revenue derives from the Individual Retirement segment.

Share on Social Networks: